APA (7th ed.) Citation

A, d. R., J, H., D, V., B, B., PR, D., D, P., . . . H, S. (2024). Efficient Dual Cas9 Nickase Correction of a Prevalent Pathogenic LAMB 3 Variant for Junctional Epidermolysis Bullosa. JID innovations : skin science from molecules to population health, 5(3), 100343. https://doi.org/10.1016/j.xjidi.2024.100343

Chicago Style (17th ed.) Citation

A, du Rand, Hunt J, Verdon D, Buttle B, Dunbar PR, Purvis D, Feisst V, and Sheppard H. "Efficient Dual Cas9 Nickase Correction of a Prevalent Pathogenic LAMB 3 Variant for Junctional Epidermolysis Bullosa." JID Innovations : Skin Science from Molecules to Population Health 5, no. 3 (2024): 100343. https://doi.org/10.1016/j.xjidi.2024.100343.

MLA (9th ed.) Citation

A, du Rand, et al. "Efficient Dual Cas9 Nickase Correction of a Prevalent Pathogenic LAMB 3 Variant for Junctional Epidermolysis Bullosa." JID Innovations : Skin Science from Molecules to Population Health, vol. 5, no. 3, 2024, p. 100343, https://doi.org/10.1016/j.xjidi.2024.100343.